TOXICOLOGICAL STUDIES ON PIPEMIDIC ACID. V. EFFECT ON DIARTHRODIAL JOINTS OF EXPERIMENTAL ANIMALS
スポンサーリンク
概要
- 論文の詳細を見る
Pipemidic acid (PPA) orally given in a dose of 100 mg/kg/day or more was found to cause lame gait in immature beagle dogs of about 3 months old. Their diarthrodial joints were abnormal with increased synovial fluid and blister formation under the outer layer of the articular cartilage. However, such an abnormality was not found in dogs younger than 2 weeks or older than 12 months. The blisters were formed at the joint areas bearing the body weight at a time when PPA was considered to be present there. Nalidixic and piromidic acids, structural analogues of PPA, also caused abnormality similar to PPA. The severity of the arthropathy was slight with piromidic acid as compared with PPA and nalidixic acid. The gait abnormality was almost disappeared spontaneously even if medication was continued. The incidence of the arthropathy was not or rarely observed in any young rats, rabbits and monkeys.
- 日本トキシコロジー学会の論文
- 1978-11-15
著者
-
Takemoto Yuichi
Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
TATSUMI Hiroshi
Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
SENDA Hiromi
Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
YATERA Seiji
Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
YAMAYOSHI Michiko
Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
OHNISHI Kumio
Research Laboratories, Dainippon Pharmaceutical Co., Ltd.
-
Senda Hiromi
Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
Yatera Seiji
Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
Ohnishi Kumio
Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
Yamayoshi Michiko
Research Laboratories Dainippon Pharmaceutical Co. Ltd.
-
Tatsumi Hiroshi
Research Laboratories Dainippon Pharmaceutical Co. Ltd.
関連論文
- TOXICOLOGICAL STUDIES ON PIPEMIDIC ACID. V. EFFECT ON DIARTHRODIAL JOINTS OF EXPERIMENTAL ANIMALS
- On Osteogenic Sarcoma Occurring in Spontaneously Hypertensive Rats
- Binding characteristics of (3H)quinupramine to rat brain membrane fractions.